Moreover, coronary microvascular dysfunction is a hallmark of HF with preserved ejection fraction (HFpEF); promoting or recapitulating the bioactivity of endothelium-derived CNP might represent a new approach to reversing this issue as a disease-modifying therapy. Here, CNP is linked to hydrops fetalis.